Ureteral stone. Calculus of lower urinary tract
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving Omnic (Tamsulosin) 0.4 mg: 30 capsules: one daily, Cefixime 400 mg: 10 tablets: one daily and Naproxen 500 mg: 20 capsules: one every 12 hours af
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients candidates for Transurethral lithotripsy surgery for unilateral ureteral stones for the first time Age range 18-50 years Consent to participate in the study
Exclusion criteria
Exclusion criteria: No symptoms of BPH No history of any disease and treatment for prostatitis, cystitis and urinary symptoms No chronic side pain No history of ureteral stent placement in any of the ureters Not pregnant No history of urinary tract infection No history of chronic gastrointestinal pain No psychological illness, Malignancy No history of allergies or side effects of Tamsulosin and Tolterodine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduce complications from ureteral stents. Timepoint: The first day of surgery and one week after taking the medication, and before removing the stent. Method of measurement: Clinical Symptoms Questionnaire, Urine test and abdominal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Akram Mirzaei
Tehran University of Medical Sciences
Outcome results
None listed